6190 PhoenixBio Co.,Ltd.フェニックスバイオTSE Growth / Services
0 posts
PhoenixBio Co.,Ltd. stock plunged on Nov 20: what happened
It closed at ¥219 on Nov 20 (−¥30.0, −12.05%), ranking #31 among the top losers of all stocks on the Tokyo Stock Exchange.
No disclosures were found for this stock around that day. Share what you know in the posts below.
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
PhoenixBio Co.,Ltd. (6190) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
PhoenixBio Co.,Ltd. (6190) Stock Price HistoryNear an all-time low
PhoenixBio Co.,Ltd. closed at ¥219 on Nov 20, 2026, −29.4% over 1 month, −47.1% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥70,645 today (−29.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −29.4%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥219 | −30 | −12.05% |
| Nov 19 (Thu) | ¥249 | +0 | +0.00% |
| Nov 17 (Tue) | ¥249 | −1 | −0.40% |
| Nov 16 (Mon) | ¥250 | −10 | −3.85% |
| Nov 13 (Fri) | ¥260 | +2 | +0.78% |
| Nov 12 (Thu) | ¥258 | +7 | +2.79% |
| Nov 11 (Wed) | ¥251 | +14 | +5.91% |
| Nov 10 (Tue) | ¥237 | +1 | +0.42% |
| Nov 9 (Mon) | ¥236 | −8 | −3.28% |
| Nov 6 (Fri) | ¥244 | −12 | −4.69% |
If you had invested ¥100,000 3 months ago, it would be worth ¥62,931 today (−37.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −37.1%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥219 | −30 | −12.05% |
| Nov 19 (Thu) | ¥249 | +0 | +0.00% |
| Nov 17 (Tue) | ¥249 | −1 | −0.40% |
| Nov 16 (Mon) | ¥250 | −10 | −3.85% |
| Nov 13 (Fri) | ¥260 | +2 | +0.78% |
| Nov 12 (Thu) | ¥258 | +7 | +2.79% |
| Nov 11 (Wed) | ¥251 | +14 | +5.91% |
| Nov 10 (Tue) | ¥237 | +1 | +0.42% |
| Nov 9 (Mon) | ¥236 | −8 | −3.28% |
| Nov 6 (Fri) | ¥244 | −12 | −4.69% |
If you had invested ¥100,000 6 months ago, it would be worth ¥51,408 today (−48.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −48.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥219 | −21.2% |
| Oct 2026 | ¥278 | −12.3% |
| Sep 2026 | ¥317 | −7.0% |
| Aug 2026 | ¥341 | −2.3% |
| Jul 2026 | ¥349 | +5.8% |
| Jun 2026 | ¥330 | −22.0% |
| May 2026 | ¥423 | −3.4% |
If you had invested ¥100,000 1 year ago, it would be worth ¥52,899 today (−47.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −47.1%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥219 | −21.2% |
| Oct 2026 | ¥278 | −12.3% |
| Sep 2026 | ¥317 | −7.0% |
| Aug 2026 | ¥341 | −2.3% |
| Jul 2026 | ¥349 | +5.8% |
| Jun 2026 | ¥330 | −22.0% |
| May 2026 | ¥423 | −3.4% |
| Apr 2026 | ¥438 | −0.5% |
| Mar 2026 | ¥440 | −10.8% |
| Feb 2026 | ¥493 | +7.9% |
| Jan 2026 | ¥457 | −5.6% |
| Dec 2025 | ¥484 | +4.1% |
| Nov 2025 | ¥465 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥45,720 today (−54.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −54.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥219 | −54.8% |
| 2025 | ¥484 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥37,500 today (−62.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −62.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥219 | −54.8% |
| 2025 | ¥484 | ― |
If you had invested ¥100,000 in Apr 2016, it would be worth ¥7,906 today (−92.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +262.3%, while this stock moved −92.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥219 | −54.8% |
| 2025 | ¥484 | +46.7% |
| 2024 | ¥330 | −29.2% |
| 2023 | ¥466 | −31.6% |
| 2022 | ¥681 | +34.1% |
| 2021 | ¥508 | −13.8% |
| 2020 | ¥589 | −29.0% |
| 2019 | ¥829 | +24.7% |
| 2018 | ¥665 | −40.9% |
| 2017 | ¥1,125 | −40.8% |
| 2016 | ¥1,900 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2016). Please check the latest prices before trading.
PhoenixBio Co.,Ltd. (6190) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of PhoenixBio Co.,Ltd. (6190)
Business overview
The company operates a single segment whose main business is contract testing services for drug development using PXB-mice, chimeric mice with human liver cells. It has the technology to create PXB-mice in which more than 70% of the mouse liver has been replaced with human liver cells, and because they can predict how drugs are metabolized in humans, it conducts contract dosing studies of drug candidates for pharmaceutical companies. PXB-mice can also be used to study hepatitis B and C viruses, which infect only human liver cells, and are used in developing antiviral drugs. It has two consolidated subsidiaries.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Services (532 companies)
| PER | 11.6x | Below the sector median of 12.9x (No. 182 from the lowest) |
|---|---|---|
| PBR | 0.62x | Below the sector median of 1.49x (No. 37 from the lowest) |
| ROE | 5.31% | No. 368 in the sector (highest first); median 12.16% |
| Market cap | ¥0.9 bn | No. 528 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥605 | 2025/12/8 |
|---|---|---|
| 52-week low | ¥219 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥219) |
| Year to date | -54.8% | No. 501 of 524 in the sector (best first) |
| 1 year | -47.1% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 losers | 2 times | Latest: 11/20 (No. 31) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/18 15:00(開示事項の経過)連結子会社の清算結了に関するお知らせ
- 11/13 15:402027年3月期第2四半期(中間期)連結業績予想と実績値との差異及び通期連結業績予想の修正に関するお知らせ
- 11/13 15:402027年3月期第2四半期(中間期)決算短信[日本基準](連結)
Filings from the past 12 months (3).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.